[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369822-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369822-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","precision-prevention-studies-a-targeted-approach-to-cancer-prevention-key-challenges-and-guidance","Precision Prevention Studies - A Targeted Approach to Cancer Prevention - key challenges and guidance","","Precision prevention studies (PPS) are biologically driven interception trials carried out in high cancer risk groups, aiming to be smaller, faster, and cheaper than traditional population-based phase III prevention trials. Rising cancer incidence and the high share of preventable cancers create urgency, yet conventional methodologies struggle to assess safety and efficacy efficiently, often yielding limited changes in practice. PPSs target biological vulnerabilities, evaluate toxicity and efficacy with surrogate endpoints, and develop or validate biomarkers, addressing design risks and mitigations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/precision-prevention-studies-a-targeted-approach-to-cancer-prevention-key-challenges-and-guidance/369822/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/precision-prevention-studies-a-targeted-approach-to-cancer-prevention-key-challenges-and-guidance/369822.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are precision prevention studies (PPSs) and how do they differ from traditional cancer prevention trials?","Question",{"text":63,"@type":64},"PPSs are biologically driven interception studies in high cancer risk groups. They are designed to be smaller and to use surrogate endpoints, contrasting with traditional large-scale phase III trials that are expensive, slow, and often not biologically targeted.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the main goal of PPSs?",{"text":68,"@type":64},"The goal of PPSs is to study preventive interventions matched to biological vulnerabilities in specific high-risk settings. PPSs investigate biological impact, define toxicity and efficacy, and discover or validate biomarkers to advance interventions.",{"name":70,"@type":61,"acceptedAnswer":71},"Where can PPSs be conducted and what conditions must be met?",{"text":72,"@type":64},"PPSs can be conducted in primary, secondary, or tertiary settings. The evaluated intervention must be biologically targeted and measurable, aligning with principles drawn from precision oncology.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369822,1790855975,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Precision Prevention Studies: A Targeted Approach to Cancer Prevention  \nSarah P. Blagden1, Kevin W. Dodd2, Karen Brown3, and Eva Szabo2  \n|  |  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 􀀶 |  | Precision prevention trials are biologically driven intercep\u003Cbr>tion studies conducted in high cancer risk groups. These are\u003Cbr>smaller, potentially faster, cheaper, and more commercially |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | attractive than traditional large-scale population prevention\u003Cbr>studies. In this article, we discuss the key challenges of con\u003Cbr>ducting precision prevention research and their mitigations. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nThe incidence of cancer is rising and, of the 18 million cancers currently diagnosed annually worldwide, it is estimated that more than 60% are preventable, not only with lifestyle adaptations such as smoking cessation but also with active interceptions like vaccines or targeted medications (1) . An example is the human papillomavirus vaccine which, in the United Kingdom, has already led to an 87% population level reduction in cervical cancer among those vaccinated during childhood through the National Health Service (NHS) national vaccination program (2) . Effective prevention has the potential to reduce cancer’s societal burden and is increasingly a priority for funders and governments (3) . However, it is challenging for cancer researchers to efficiently evaluate the safety and efficacy of preventive agents using existing clinical trial methodologies. Traditional population-based phase III cancer prevention trials, when not targeted to very high–risk populations, are expensive and slow, taking an average of 10 to 15 years (4–7) . They have tended to evaluate repurposed drugs or diet-derived micronutrients and vitamins in nonbiologically selected participants and have limited scope for exploring biological hypotheses. With a few notable exceptions, these studies have largely failed to change practice or prompt positive licensing decisions, factors that have made cancer prevention unattractive to pharmaceutical and biotechnological investors (8) . Precision prevention studies (PPS) have the potential to overcome these limitations as they differ from traditional population prevention studies in multiple aspects,  \n1Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, United Kingdom. 2Division of Cancer Prevention, National Cancer Institute, Bethedsa, Maryland. 3Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom.  \nCorresponding Author: Sarah Blagden, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ,  \nUnited Kingdom. E-mail: [sarah.blagden@oncology.ox.ac.uk](sarah.blagden@oncology.ox.ac.uk)  \n[Cancer Prev Res 2025](Cancer Prev Res 2025);[18:499](18:499)–[507](507)  \n[doi:](doi: 10.","cbCaisUb7z5C6OeQ","https://ap.wps.com/l/cbCaisUb7z5C6OeQ","pdf",2798219,"English","# Introduction\n# Defining the aims of PPSs","[{\"question\":\"What are precision prevention studies (PPSs) and how do they differ from traditional cancer prevention trials?\",\"answer\":\"PPSs are biologically driven interception studies in high cancer risk groups. They are designed to be smaller and to use surrogate endpoints, contrasting with traditional large-scale phase III trials that are expensive, slow, and often not biologically targeted.\"},{\"question\":\"What is the main goal of PPSs?\",\"answer\":\"The goal of PPSs is to study preventive interventions matched to biological vulnerabilities in specific high-risk settings. PPSs investigate biological impact, define toxicity and efficacy, and discover or validate biomarkers to advance interventions.\"},{\"question\":\"Where can PPSs be conducted and what conditions must be met?\",\"answer\":\"PPSs can be conducted in primary, secondary, or tertiary settings. The evaluated intervention must be biologically targeted and measurable, aligning with principles drawn from precision oncology.\"}]","Precision Prevention Studies - A Targeted Approach to Cancer Prevention - key challenges and guidance | PDF",1790184754,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1eee2cc0eab84ac2aea44948bb3eb9e1.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c4c5243033db79de9234a50787ec2f6.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51cff4417ae5645821e1aadeebcf241d.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efcf203176cba6b64da7948fd0e2e09a.webp",980,1311]